Wednesday, August 20, 2008 Free Registration Log-in to View Profiles
Empire Relations Group is a Premier Investor Relations Organization representing publicly-traded companies in their communications programs with existing shareholders and potential investors.
investments
OTCBB
OTCBB
Pressroom 
 
 Archived
 
 Non-Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
 
 Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
Search


Non-Public Companies : Healthcare/BioTech


MarketResearch.com Announces Distribution of JZMed, Inc. Research

Jun 27, 2008 - 10:36:01 AM

News Source MARKET WIRE

Email this article
 Printer friendly page
NEW YORK, NY -- (MARKET WIRE) -- 06/27/08 -- As the leading distributor of marketintelligence, MarketResearch.com is pleased to announce a businesspartnership with JZMed, Inc., which allows for the marketing anddistribution of JZMed's proprietary market analyses through theMarketResearch.com website.

The new relationship offers business professionals throughout the worldeasy access to complete product descriptions and tables of contents fromresearch publications authored by JZMed, Inc. At the same time, visitors tothe MarketResearch.com website have the ability to purchase the materialdirectly through MarketResearch.com's secure server.

"Our ability to join hands with exceptional research publishers such asJZMed, Inc. allows us to not only broaden the scope of research availablein the pharmaceutical outsourcing market, it also allows businessprofessionals throughout the world easier access to reports of great valuethat they may have previously been unaware of," notes Kelly M. Carlson,Vice President, Publisher Relations and Business Development ofMarketResearch.com.

JZMed, Inc. has published a series of market research reports that havegreatly helped all kinds of outsourcing companies in the pharmaceutical andbiotechnology industry navigate the complex process of pharmaceuticaloutsourcing in China.

"Teaming up with MarketResearch.com is an exceptional opportunity for us asour product line is an excellent fit for this resource avenue," accordingto Jim J. Zhang, Ph.D., CEO of JZMed, Inc. "We believe that the increasedexposure our products will receive through MarketResearch.com's web trafficand sales force will have a positive impact on our business as our reportsmake it into the hands of a wider global audience."

For further information about JZMed, Inc. reports, visithttp://www.marketresearch.com/redirect.asp?progid=8418&vendorid=3594.

About MarketResearch.com

MarketResearch.com is the leading provider of global market intelligenceproducts and services. With over 160,000 research reports from more than600 top consulting and advisory firms, MarketResearch.com offers instantonline access to the world's most extensive database of expert insights onglobal industries, companies, products, and trends. For more information,call Tom Ehart at 240-747-3014 or visit www.MarketResearch.com.

About JZMed, Inc.

JZMed, Inc. is a leading pharmaceutical outsourcing service providerspecializing in a full scale service for pharmaceutical outsourcing inChina. It also provides market research services to companies wishing toenter the Chinese pharmaceutical market.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Tom Ehart
MarketResearch.com
240.747.3014
tehart@marketresearch.com



Top of Page | Main News Index | EmpireRelations.com Home Page EmpireRelations.com Selected Clients News

Come see our services. Copr. © 2005 Empire Relations Group, Inc.

Healthcare/BioTech
Latest Headlines
Qualia Clinical Services Strengthens Financial Team
Boston Medical Center Uses Envox 7 to Pioneer a New Healthcare Delivery Model
NCSBN Inducted Its Second Group of Fellows of the NCSBN Regulatory Excellence Institute on Aug. 6, 2008, During Its Annual Meeting and Delegate Assembly
Live at Millennium Monument Park -- 2008 Olympic Athletes: Bringing a New Vision to Competition
Wolf Greenfield Wins Three More Years of Patent Protection for Shire Pharmaceuticals' ELAPRASE
New Study Finds Parents Embrace Alternative Treatments for Children's Asthma
Cutting Edge Information's Research Shows Market for Breast Cancer Drugs to Top $40 Billion by 2012
SPEEDEL SHAREHOLDERS ELECT FOUR NOVARTIS OFFICERS AS NEW MEMBERS TO THE BOARD OF DIRECTORS
Government of Canada Contributes $18-Million in Support of Red Cross Relief Efforts in China and Myanmar
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer